InvestorsHub Logo
Followers 23
Posts 2674
Boards Moderated 0
Alias Born 08/25/2010

Re: justdafactss post# 93064

Saturday, 07/11/2020 7:14:39 PM

Saturday, July 11, 2020 7:14:39 PM

Post# of 232882
First paragraph

VANCOUVER, Washington, June 08, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the U.S. Food and Drug Administration (FDA) advised the Company, subject to its ongoing review, it could receive its “PDUFA date” on July 10, 2020.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News